Journal Report

BREAST CANCER

Download PDF
Journal Information
Journal Title
BREAST CANCER
Publisher
SPRINGER JAPAN KK
ISSN
1340-6868
E-ISSN
1880-4233
Database
Clarivate
Domain
Health Sciences, Life Sciences, Physical Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Feasibility and safety of intraoperative photodynamic diagnosis using 5-aminolevulinic acid in breast cancer surgery
Haruru Kotani, Ayako Isogai, Akira Nakakami et al.
2026-11-6
Longitudinal PRO-CTCAE assessment in patients with HR+/HER2 − metastatic breast cancer initiating palbociclib: feasibility and symptom trajectories in a multicenter prospective cohort study
Takayuki Iwamoto, Yukari Uemura, Takashi Ishikawa et al.
2026-11-6
Nonlinear association between age and volumetric breast density in Japanese women
Mai Matsubara, Takayoshi Uematsu, Takahiro Ito et al.
2026-11-5
Predicting neoadjuvant chemotherapy efficacy in triple-negative breast cancer using DCE-MRI and mammographic texture
Shubo Gao, Jing Luo, Jing Zhang et al.
2026-11-4
Methodological considerations in evaluating bioelectrical impedance and quality of life in breast cancer: NACT confounding, generalizability of standing devices, and fluid asymmetries
Surhan Indra
2026-11-3
Perioperative outcomes of CO2 insufflation and retractor-assisted endoscopic nipple-sparing mastectomy: a single-institution retrospective study
Naomi Sakamoto, Hiroshi Nakamura, Takehiro Yamada et al.
2026-10-31
Evaluations of significant loci associated with mammographic breast density in Korean women
Somin Jeon, Han-Na Kim, Yoonyoung Jang et al.
2026-10-30
Prognostic performance of the Japanese Breast Cancer Society pathological response classification after neoadjuvant chemotherapy
Yumiko Ushiyama, Yuko Ueki, Yoshiya Horimoto et al.
2026-10-27
Molecular mechanisms and targeted therapeutic strategies of TIGAR in regulating energy metabolism to promote tumor proliferation in breast cancer
Mengyi Zhai, Peiying Wang, Yetao Ou
2026-10-25
A phase II study combining radiotherapy and atezolizumab/nab-paclitaxel for inoperable or recurrent programmed death-ligand 1-positive triple-negative breast cancer: IMRad-Br study protocol and safety run-in
Hiroshi Ishiguro, Nobuhiro Hoshi, Shin-ei Noda et al.
2026-10-21
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 7, 2026 21:13